{
    "2018-03-09": [
        [
            {
                "time": "2018-03-15",
                "original_text": "More Prison Inmates Get Access to Hepatitis-C Drugs",
                "features": {
                    "keywords": [
                        "Prison",
                        "Inmates",
                        "Hepatitis-C",
                        "Drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Top 4 Marijuana Stocks to Watch",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Stocks",
                        "Watch"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?",
                "features": {
                    "keywords": [
                        "Big",
                        "Pharma",
                        "Corporate",
                        "Tax",
                        "Savings",
                        "Lower",
                        "Drug",
                        "Costs"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Zacks Value Investor Highlights: Diageo, Mylan, Sony, AbbVie and Walgreens",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Value",
                        "Investor",
                        "Diageo",
                        "Mylan",
                        "Sony",
                        "AbbVie",
                        "Walgreens"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Todayâ€™s Research Reports on Trending Tickers: AbbVie Inc. and Amgen Inc.",
                "features": {
                    "keywords": [
                        "Research",
                        "Reports",
                        "Trending",
                        "Tickers",
                        "AbbVie",
                        "Amgen"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "AbbVie Inc (NYSE:ABBV): Time For A Financial Health Check",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Financial",
                        "Health",
                        "Check"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}